European GMPs and the Role of the Qualified Person (QP) (Day 1 and 2) + Clinical Trial Supplies (Day 3) – Live Online Training
Objectives
Background
The Pharmaceutical Industry has become more global due to international collaborations, mergers and acquisitions and more complex supply chains require companies to have a greater understanding of pharmaceutical legislation throughout the world. This is becoming increasingly evident by the number of non-EU professionals contacting the European Compliance Academy and the Qualified Persons Association asking for more and more detailed information about the European GMPs and the unique role and responsibility of the EU QP.
The ECA Academy and the European QP Association, recognising this need for further professional knowledge development, intend to support the pharmaceutical industry outside Europe in understanding the EU approach and legal framework in this respect. Therefore, the QP Association has set up the Programme at hand on European GMP requirements and the role of the QP.
In light of the establishment of a Mutual Recognition Agreement between US and EU and the parallel move out of Great Britain from the EU, representatives from the authorities as well as QPs and well-known experts will talk about the current issues and share their point of view.
Target Group
Technical Requirements
Programme
The EU Pharmaceutical Legislation and the respective Inspection System
- EU legislation and relevant guidance documents (overview)
- The EU inspection System
- Non-compliance with EU-GMP and authority Actions
- EU Manufacturing Authorisation & EU-GMP Certificate
- MRA: impact for Industry
- Exchange on GMP-information between US and EU
- Annex 21 of the EU-GMP Guidelines
- Import of Medicinal Products and APIs into the European Union
- Which types of materials do fall under EU import legislation?
- Regulatory requirements for Import
- Which documents are needed for import activities of medicinal products and APIs
- Regulatory procedure to get an import Licence
- Procedure if a non-EU company imports to different EU Member States
- Batch certification and release for the EU Market
- Directive 2001/83/EC; Article 49 – “conditions of qualification”
- Annex 16 of the EU-GMP Guidelines
- The role of the QP within the pharmaceutical quality System
- What the QP is responsible for
- The QP’s margin of discretion when certifying batches with deviations
- Supply Chain oversight and supply chain diagram
- QP Declaration
- GDP requirements
- Importers, brokers, local affiliates, pre-wholesalers, wholesalers, parallel Import
- Serialisation
- Virtual companies
- UK and EU Point of View
- The Northern Ireland Protocol
- Impact on the roles and responsibilities of the QP
- What companies outside Europe need to be aware of
- Examples of complications
- Complaint and recall handing
- The QP and the QPPV
- When to contact the authorities
Clinical Trial Supplies: IMP Handling in Europe and the Role of the QP
- Current and future EU-GMP and QP requirements
- Certification and release of Investigational Medicinal Products (IMPs) for studies in the EU
- Specific aspects of IMP supply chains
- GMP-GCP Interface
- QP oversight and being a QP in a global environment
When attending live online, a set of live Q&A Sessions will give you the possibility to interact with the Speakers and get answers to your questions.
This training/webinar cannot be booked. Send us your inquiry by using the following contact form.
To find alternative dates for this training/webinar or similar events please see the complete list of all events.
For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.
not available
not available
Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org
Testimonials
